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Propolis is increasingly being explored as a source of biologically active compounds. Until now 
there has been no study of Libyan propolis. Two samples were collected in North East Libya and 
tested for their activity against Trypanosoma brucei . Extracts from both samples  had quite high 
activity. One of the samples was fractionated and yielded a number of active fractions. Three of 
the active fractions contained single compounds which were found to be 13-epitorulosal, acetyl-
13-epi-cupressic acid  and 13-epi-cupressic acid which have been described before in 
Mediterranean propolis. Two of the compounds had MIC valuesof 1.56 µg/ml against T.brucei. The 
active fractions were also tested against  macrophages infected with Leishmania donovani  and 
again moderate to strong activity was observed with the compounds having IC50 values in the 
range 5.1-21.9 µg/ml. 
Keywords Libyan propolis, labdane diterpenes, T. brucei, L. donovani. 
INTRODUCTION 
Propolis is harvested by honey bees in order to seal cracks of the hives and more importantly 
eliminate biological contamination in the colony. It has been reported to have various biological and 
pharmacological properties and is potentially a source of new medicines particularly for treating 
infective diseases  (Sforcin and Bankova, 2011; Salatino et al,2011; Bankova et al, 2000) . Propolis 
has the advantage as a source of biologically active compounds since it has already been selected by 
bees for its biological activity and is collected from plants in a non-destructive way. The chemical and 
bioactive characteristics of propolis are highly dependent on its geographic origin (Seidel et al, 2008; 
Watson et al 2006; Salatino et al, 2005). Although it has never been proved, it would seem likely that 
the plants chosen by the bees in a particular location would exhibit activity against the 
environmental pressures encountered by the bees which include protozoal attack (Ruiz-Gonzales 
and Brown 2006). In a simulated experiment, artificial nectar containing the alkaloid gelsemine, 
which is also naturally contained in a source of nectar favoured by North American bumblebees, was 
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ingested by bumblebees and found to reduce the pathogen load of the protozoan parasite Crithidia 
bombi  (Manson et al 2010).  A number of previous studies have tested propolis against both 
Trypansoma and Leishmania species, these studies have largely focused on the use of extracts rather 
than isolated compounds.  Extracts from two samples of Portuguese propolis were investigated for 
their activity against Plasmodium falciparum, Leishmania infantum, Trypanosoma brucei and 
Trypanosoma cruzi (Falcão et al, 2014). IC50 values were mainly < 10 µg/ml and the greatest activity 
of 1.8 µg/ml being against T.brucei.  The anti-leishmanial activity of Turkish propolis was investigated 
( Duran et al 2011) and the two samples tested had IC50 values of 175 and 350 µg/ml. The effect of 
an extract of Brazilian propolis on Trypanosoma evansi was investigated (Gressler et al 2012) and in 
vitro the IC50 value for the extract was found to be 10µg/ml, but the propolis was ineffective in 
curing rats infected with T.evansi.  Extracts of eighteen Cuban propolis extracts of different types 
were tested against Leishmania amazonenis  ( Fidalgo et al 2011). All of the extracts produced 
inhibition of L.amazonenis but they also displayed some toxicity against macrophages. Compounds 
isolated from  Baccharis dracunculifolia, which is the major source of Brazilian green propolis, were 
investigated for antileishmanial and antiplasmodial activity ( Da Silva et al, 2009). Ursolic acid and 
hautriwaic acid lactone had IC50 values of 3.7 and 7 µg/ml against Leishmania donovani.  The activity 
of Brazilian green propolis against T.cruzi was investigated (Salomão et al, 2011). The extract was 
most effective against the intra-cellular amastigote stage of the parasite having an IC50 values of 8.5 
µg/ml.  Extracts of Brazilian red and Brazilian green propolis were tested against L. amazonensis ( 
Ayres et al 2007) and an extract of red propolis was found to be the most effective having an MIC of 
25 µg/ml.  Bulgarian propolis extracts were found to have IC50 values of 36-40 µg/ml against  T.cruzi 
( Dantas et al 2006). Thus it is apparent that anti-protozoal activity of propolis is common to propolis 
samples from many regions.  Within this context, our study investigated the effect of Libyan propolis 
on the parasites Trypanosoma brucei brucei, which is the etiologic agent of sleeping sickness and 
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Leishmania donovani  which causes visceral leishmaniasis. The biological properties and chemical 
profile of Libyan propolis have not been investigated before. 
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MATERIALS  AND METHODS 
Materials 
Absolute ethanol, HPLC grade acetonitrile, hexane, methanol,  formic acid  and Acrodisc syringe 
filters were obtained from  (Fisher Scientific, Loughborough UK). Chloroform, DMSO, deuterated 
chloroform, D6 DMSO, silica gel  60, 0.04 -0.06mm mesh size and Wilmad NMR tubes were obtained 
from Sigma Aldrich, Dorset, UK. An ACE C18 column ( 3mm x 150mm, 3µm) was from Hichrom, 
Reading, UK. T.brucei  (ATCC S427 blood stream form) was from Fisher Scientific, UK. HPLC grade 
Water was produced in house by a Milli Q system (Millipore, UK). RPMI 1640 medium, DMEM, 
penicillin-streptomycin, and L-glutamine were obtained from Gibco BRL, Paisley UK. D-luciferin 
potassium salt was obtained from Caliper Life Science, Massachusetts, USA. Amphotericin B was 
purchased from Sequoia Research Products (Berkshire, UK). 
    Two propolis samples were collected from Tokra or Tukra ,Al `Aquriyah, Libya, a small village in 
Eastern Libya, located about 70 km East of Benghazi city (LBA) and from Qaminis 53 km South of 
Benghazi (LBG).  The beekeeper scraped the propolis sample off the top of the hive using a spatula 
and collected it in a clean tray.  LBA possessed an intense orange like odour, was light brown and 
had a very sticky texture while LBG was darker brown, less sticky and had a less intense odour. A 
sample of the LBA propolis (23g) was extracted by sonication in 100 ml of absolute ethanol for 60 
minutes then the extract was filtered and re-extracted twice more with 100 ml of ethanol, filtering 
each time after that and the extracts were combined and the solvent was evaporated. The crude 
ethanolic extract was tested against T. brucei. 
Animals  
Luciferase-expressing L. donovani promastigotes were derived from Leishmania donovani strain 
MHOM/ET/67:MHOM/ET/67: LV82 (XXX). In-house inbred male BALB/c mice (20-25 g) were used in 
studies. All animal studies were carried out in accordance with the Animals (Scientific Procedures) 
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Act 1986 and had UK Home Office approved and local ethical approval from the University of 
Strathclyde.  
Open Column Chromatography and Medium Pressure Liquid Chromatography 
A sample (2g) of the ethanolic extract of the propolis was dissolved in ethyl acetate and mixed with 6 
g of silica gel in a beaker and the solvent was removed slowly under a stream of nitrogen. Then silica 
gel (50 g) was mixed with hexane (200ml) and used to pack a glass column. The sample mixed with 
silica gel was dry loaded onto the top of the column and elution was carried out as follows collecting 
fractions in 50 ml flasks: 200ml of hexane/ethyl acetate, (90:10) F1 , then 200 ml of hexane/ethyl 
acetate (60:40) F2 , then 200ml of hexane /ethyl acetate  (40:60) F3, 200ml of ethyl acetate F4  and 
200 ml of methanol F5  and finally 200ml of methanol/water (60:40) F6. All fractions obtained from 
open column chromatography were concentrated by rotary evaporation and weighed. Fraction F1-3 
which had the highest weight was fractionated by medium pressure liquid chromatography (MPLC) 
on silica gel using a Grace Revelris Flash Chromatography system (Alltech Ltd. UK) with evaporative 
light scattering (ELSD) detection and UV detection. The sample was loaded onto celite (1.9g) and 
packed into a dry loading cartridge. The Revelris MPLC was set up with a 24 g silica gel column to run 
a stepwise gradient at 12 ml/min flow rate using linear gradients as follows: 100% hexane 0 min.; 
hexane ethyl acetate (80:20) 30 min.; 100% ethyl acetate 50  min.  Fractions were collected 
automatically when triggered by the ELSD response. The fractions associated with the same peak 
according to the ELSD chromatogram were combined and the solvent was removed and they were 
weighed. The isolated fractions were profiled by reversed phase HPLC with ELSD;   GC-MS, LC-MS 
and NMR. 
Instrumental Methods 
Fractions from the MPLC separation were profiled using an Agilent 1100 HPLC linked to a Shodex 
ELSD. An  ACE C18 column (150 × 3 mm, 3 µm)) with a mobile phase of water (A) and  acetonitrile (B)  
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with a flow rate of 0.5 ml/min and the following gradient: 0 min 70% B ;20 min. 100% B, 26 min. 
100% B. The samples were prepared at 0.5 mg/ml by dissolving in acetonitrile and then adding water 
to give a solution in water/acetonitrile (30:70).            
             
The crude sample, fractions obtained from chromatography and the purified compounds 
obtained from flash chromatography were dissolved in methanol and analysed by LC-MS in order to 
confirm their masses and molecular formulae. The high resolution mass spectra were obtained by 
using an LTQ Orbitrap mass spectrometer (ThermoFisher, Hemel Hempstead, UK) in negative ion 
mode with a needle voltage of -4.0 kV. Samples were dissolved in methanol to give 1mg/ml and the 
ƐĂŵƉůĞƐŽůƵƚŝŽŶ ? ? ?ʅů ?ǁĂƐinjected. The separation was performed on an ACE C18 column (150 × 3 
mm, 3 µm) from HiChrom UK with 0.1% v/v formic acid in water as mobile phase A and 0.1% v/v 
formic acid in acetonitrile as B at flow rate of 0.300ml/min using the gradient  described for HPLC-
ELSD. 
Nuclear Magnetic Resonance Spectroscopy (NMR) 
Samples (5-10 mg) of the fractions obtained from the MPLC fractionation which exhibited good 
purity were dissolved in CDCl3 and transferred to NMR tubes. 
1
H NMR spectra were measured at a 
magnetic field strength of 400.13 MHZ using a JEOL Delta GX 400 MHz FT nuclear magnetic 
resonance instrument. Proton spectra were referenced to the residual protons in CDCl3. Broad band 
decoupled 
13
C NMR was used to determine the number of carbons, their type and where necessary 
DEPT experiments were obtained in order to distinguish the carbons according to the extent of their 
proton attachments.  Correlation spectroscopy (COSY), Heteronuclear Multiple-Bond Correlation 
Spectroscopy (HMBC) and Heteronuclear Multiple Quantum Coherence (HMQC) spectra were also 
obtained. 
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  Optical rotation measurements were obtained by using a Perkin Elmer 341 polarimeter. The 
samples were dissolved in 2 ml of chloroform and measured using the sodium D line. 
Antimicrobial assays 
a) Trypanosome studies The in vitro anti-trypanosomal tests were carried out by using an 
AlamarBlue
TM
 assay according to a standard protocol (Raz et al 1997; Igoli et al 2012).  
b) L. donovani studies  
Intraperitoneal macrophages were recovered from the peritoneal cavity of BALB/c mice 3 days after 
intraperitoneal injection with 1 ml 3% w/v aqueous sterile starch solution. The mice were then 
euthanized and 3 ml of incomplete medium (RPMI- ? ? ? ? ?  ? ? ?ʅŐ ?ŵů penicillin-streptomycin and L-
glutamine) was injected into the peritoneal cavity. The macrophage-containing medium was then 
removed and collected and the resulting cell suspension centrifuged at 3000 x g for 5 minutes and 
then re-suspended in 10 mls complete medium (in complete RPMI-1640 supplemented with 10% 
heat inactivated FCS [v/v]). The cells were then used in antileishmanial assays. Bone marrow was 
then harvested from the femurs of each mice by flushing out the removed bone with 5 mls of bone 
marrow medium (DMEM, 20% heat-inactivated FCS [v/v], 30% L-Cell solution [v/v],  ? ? ? ʅŐ/ml 
penicillin-streptomycin, and L-glutamine). The cell suspension was added to sterile petri dishes (one 
petri dish/mouse) and incubated for 7 days at 37°C in an atmosphere of 5% CO2:95% air. The 
medium was removed from the plate and 7 ml Tryple Express was added to detach the bone marrow 
derived macrophages.  The resulting suspension of bone marrow derived macrophages was 
collected, pelleted by centrifugation and re-suspended in 10 ml of incomplete medium and then 
used in antileishmanial assays.  
The number of live macrophages/ml was determined microscopically using a 
haemocytometer, by mixing a cell sample with  ? ? ? dƌǇƉĂŶ ďůƵĞ  ? ? ?ʅů ? ĂŶĚ ǀŝĞǁŝŶŐ Ăƚ ǆ ? ?
magnification. In all cases cell viability was >95%.  Cells (0.5x10
5
 ŝŶ  ? ? ?ʅůĐŽŵƉůĞƚĞŵĞĚŝƵŵ ? were 
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added to the appropriate wells of a 96 well tissue culture plate and incubated for 24 hours at 37°C in 
an atmosphere of 5% CO2:95% air. Cells were then infected with L. donovani luciferase-expressing 
parasite using a 20:1 parasite:host cell ratio the plate was incubated as before for 24 hours. The 
medium was removed from each well and replaced with  ? ? ?ʅůĐŽŵƉůĞƚĞŵĞĚŝƵŵ (control, n = 6) or 
various concentrations of the one of the extracts (diluted in 4% DSMO v/v in complete medium, n = 
3) or Amphotericin B solution (AMB, 4-0.02 ʅŐ ?ŵů).  The plate was incubated as before for 72 hours 
and then the medium ǁĂƐ ƚŚĞŶ ƌĞŵŽǀĞĚ ĂŶĚ  ? ? ?ʅů ŽĨluciferiŶ ƐŽůƵƚŝŽŶ  ? ? ? ?ʅŐ ?ŵů ůƵĐŝĨĞƌŝŶ ŝŶ
complete RPMI-1640) was added to each well and the BLI emitted/well was determined using the 
IVIS
®
 imaging system (Alsaadi et al., 2012). The suppression in bioluminescent signal for each test 
sample was compared to the mean control value.  The mean IC50 value was then calculated for each 
sample by Probit analysis (Vermeersch et al., 2009).   
Statistics 
Data was analysed using Minitab
®
 software version 16.1.1 supplied by Minitab Ltd. Coventry, UK, and 
an Anderson-Darling test was used to establish if the data was normally distributed. Parametric data 
was analysĞĚ ƵƐŝŶŐ Ă ^ƚƵĚĞŶƚ ?Ɛ ƵŶƉĂŝƌĞĚ ƚ-test or by one-way analysis of variance (ANOVA) 
dependent on the number of treatments/experiments and significance was confirmed by a Fisher 
test. A Mann-Whitney or Kruskal-Wallis test was used to analyse data that did not have a normal 
distribution. Results were considered statistically significant at a p value <0.05.  
RESULTS 
The results for screening the crude extracts of two propolis samples and against  T.brucei using an 
Almar blue assay are shown in table 1. Both extracts were quite active but since LBA was 
approximately two fold more active than LBG and it was selected for fractionation. First it was 
fractionated by open column chromatography and fraction 1, which was eluted with hexane/ethyl 
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acetate (90:10) and which had the highest weight, and fraction 3, which was eluted with 
hexane/ethyl acetate (40:60), were selected for further fractionation by MPLC.  The fractions 
obtained from the Grace Revelris system were analysed by HPLC-ELSD and four of the fractions were 
found to be quite pure.  The 
1
H and 
13
C
 
NMR data for the pure fractions were compared to the 
literature and the data were found to closely match the NMR data reported previously for the 
labdane diterpenes 13-epitorulosal (1), acetyl-13-epi-cupressic acid (2) and 13-epi-cupressic acid (3) 
(Abdel-Sattar et al 2009;  Wen-Chiung  et al 1994) and for the lignin (+) sesamin (4) (Christov et al 
1999) . In addition the following analytical information was obtained:  (1) Eluted mainly in fraction 9 
from the MPLC system which had a weight of 14 mg. It had an optical rotation of + 14° (lit +35°). (2) 
Eluted mainly in fraction 10 from the MPLC system which had a weight of 7 mg. It had an optical 
rotation of + 92°. (3) Eluted mainly in fraction 15 from the MPLC system which had a weight of 102 
mg. It had an optical rotation of +55.5° (lit +57°).. (4) Eluted in fraction 7 when fractionation of open 
column fraction 3 was separated using the MPLC system and it had a weight of 7 mg. The optical 
rotation of the compound was ŵĞĂƐƵƌĞĚŝŶĐŚůŽƌŽĨŽƌŵĂŶĚŐĂǀĞ ?ɲ ?сн ? ? ? ?
Biological Test Results  
The results for the fractions obtained from MPLC are shown in table 1. Most of the fractions 
contained mixtures of diterpenes with fractions 9, 10 and 15 containing the diterpenes 1-3 described 
above. None of the fractions had greater activity than the open column fraction 1 itself suggesting 
that there might be synergisitic activity between the components within the fraction. Two of the 
diterpenes, (1) and (2) which elute in fractions 9 and 10 have activity equal to the unfractionated 
material. The results illustrate that relatively small structural changes can have an effect on activity 
with the diterpene in fraction 15 being considerably less active than the compounds in fractions 9 
and 10. Thus the results point to a potential for carrying out semi-synthetic modifications of active 
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compounds in order to improve activity. In addition sesamin which was isolated from F3 by MPLC 
gave moderate anti-trypanosomal activity. 
Anti-leishmanial activity  
The MPLC fractions obtained for were also tested against L. donovani.  The results are shown in table 
2 and it can be seen that the IC50 values are somewhat variable which can be attributed to the 
difficulty in getting the compounds to dissolve in the aqueous test medium. Overall compound 3, 
which is in the most polar fraction tested, was the most consistent in terms of activity and the most 
active.  The fractions were all active and overall their activity was greater in suppressing infection of 
peritoneal macrophages than in inhibiting infection of bone marrow macrophages. Most of the 
fractions were active at concentrations well below the levels at which the commonly used 
stibogluconate treatment is effective (Carter et al 2001). The  levels of DMSO used in the samples 
were below the level where it had toxic effects on the leishmania. 
DISCUSSION 
The composition of the Libyan propolis LBA is typical of Mediterranean propolis. Profiling of Greek 
propolis was  carried out by GC-MS (Popova et al, 2010) on six samples, three collected from the 
Greek mainland and three collected in Crete. All of the samples were rich in diterpenes with 37 
diterpenes being characterised in the propolis extracts. It was proposed that the compounds were 
collected from conifer species in the Cupressaceae family. Some of these diterpenes, including 
compounds 1 and 3, were isolated from Cretan propolis (Popova et al, 2009) and tested against a 
range of bacteria against which they were found to have moderate activity. Compounds 2 and 3 
were isolated from Araucaria heterophylla resin (Abdel-Sattar et al, 2009) and were tested against 
cancer cell lines. Compounds 2 and 3 were found to be quite cytotoxic having IC50 values of 2.7 and 
9.8 µg/ml against MCF7 breast cancer cells. Thus if these compounds were to be effective anti-
parasitic drugs the therapeutic window might not be that wide. Propolis proves to consistently have 
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potent biological activity and the activity is often specific to particular micro-organisms and in the 
current case earlier testing of the constituents of Cretan propolis, two of which were found in the 
Libyan propolis sample, revealed only moderate activity against bacteria. In the current case the 
acitivity against protozoa is considerably higher. Thus the propolis may reflect the particular 
environmental pressures that the bees are subject to within the region in which the hive is sited. 
Propolis remains a fascinating substance and if in vivo activity could be demonstrated to match its in 
vitro activity it is potentially a cheap readily available antibiotic. 
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Figure 1 Structures of compounds isolated from Libyan propolis. 
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Table 1 MIC values for crude LBA and LBG extracts and fractions of LBA tested against T. brucei blood 
stream form S427. 
Sample MIC (µg/ml) 
LBA1 3.12 
LBG2 6.25 
LBAF1 1.56 
MPLC F1-2 10.00 
MPLC F1-5 5.00 
MPLC F1-7 10.00 
MPLC F1-9 (1) 2.50 
MPLC F1-10 (2) 1.56 
MPLC F1-11 1.56 
MPLC F1-14 5 
MPLC F1-15 (3) 10 
MPLC F1-16 2.5 
MPLC F1-17 2.5 
MPLC F1-18 5 
MPLC F1-20 5 
MPLC F3-7 6.5 
Suramin 0.178 
 
  
19 
 
 
Table 2 MICs of MPLC fractions obtained from LBA1-4 tested against the amastigote stage of 
L.donovani. 
Fraction 
/compound 
IC 50  µg/ml±SEM 
Peritoneal infected 
macrophages   
bone marrow derived   
macrophages 
7 43±38 (n=2) 33±20 (n=3) 
8 10.4 ± 1.6 (n=2) 22.8±7.8 (n=3) 
9 (1) 6.9±3.7 (n=3) 7.4±5.0 (n=3) 
10 (2) 7.0±4.0 (n=2) 21.9±12.3 (n=3) 
11 2.2 (n=1) 32.2±2.4 (n=3) 
15 (3) 5.1±2.1 (n=3) 6.3 ±3.7 (n=3) 
Amphotericin b 0.01±0.0 (n=2) 0.024±0.06 (n=2) 
 
